SK27193A3 - Imidazopyridine derivatives, process for their preparation and their pharmaceutical compositions - Google Patents

Imidazopyridine derivatives, process for their preparation and their pharmaceutical compositions Download PDF

Info

Publication number
SK27193A3
SK27193A3 SK271-93A SK27193A SK27193A3 SK 27193 A3 SK27193 A3 SK 27193A3 SK 27193 A SK27193 A SK 27193A SK 27193 A3 SK27193 A3 SK 27193A3
Authority
SK
Slovakia
Prior art keywords
quot
predstavuje
formula
alkyl
acid
Prior art date
Application number
SK271-93A
Other languages
English (en)
Slovak (sk)
Inventor
Werner Mederski
Dieter Dorsch
Norbert Beier
Ingeborg Lues
Klaus-Otto Minck
Pierre Schelling
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK27193A3 publication Critical patent/SK27193A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK271-93A 1992-04-06 1993-03-31 Imidazopyridine derivatives, process for their preparation and their pharmaceutical compositions SK27193A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4211474A DE4211474A1 (de) 1992-04-06 1992-04-06 Imidazopyridine

Publications (1)

Publication Number Publication Date
SK27193A3 true SK27193A3 (en) 1994-01-12

Family

ID=6456180

Family Applications (1)

Application Number Title Priority Date Filing Date
SK271-93A SK27193A3 (en) 1992-04-06 1993-03-31 Imidazopyridine derivatives, process for their preparation and their pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP0564960A1 (de)
JP (1) JPH0625239A (de)
KR (1) KR930021638A (de)
CN (1) CN1082045A (de)
AU (1) AU3673193A (de)
CA (1) CA2093290A1 (de)
CZ (1) CZ58193A3 (de)
DE (1) DE4211474A1 (de)
HU (1) HUT64342A (de)
NO (1) NO931302L (de)
PL (1) PL298392A1 (de)
SK (1) SK27193A3 (de)
ZA (1) ZA932459B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4305602A1 (de) * 1992-06-17 1993-12-23 Merck Patent Gmbh Imidazopyridine
DE4242459A1 (de) * 1992-12-16 1994-06-23 Merck Patent Gmbh Imidazopyridine
DE4341453A1 (de) * 1993-12-06 1995-06-08 Merck Patent Gmbh Imidazopyridine
DE19845153A1 (de) 1998-10-01 2000-04-06 Merck Patent Gmbh Imidazo[4,5]-pyridin-4-on-derivate
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
EP1706403B9 (de) 2003-12-22 2012-07-25 K.U.Leuven Research & Development Imidazo[4,5-c]pyridinverbindungen und verfahren zur antiviralen behandlung
SI1841765T1 (sl) 2004-12-21 2009-08-31 Gilead Sciences Inc Imidazo(4,5-c)piridinska spojina in postopek za antivirusno zdravljenje
MX2009000235A (es) 2006-07-07 2009-01-23 Gilead Sciences Inc Compuesto de piridazina novedoso y uso del mismo.
EP2091947A2 (de) * 2006-12-20 2009-08-26 Takeda San Diego, Inc. Glucokinaseaktivatoren
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
DE4110019C2 (de) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
HU9300999D0 (en) 1993-06-28
PL298392A1 (en) 1993-10-18
AU3673193A (en) 1993-10-14
ZA932459B (en) 1993-10-20
JPH0625239A (ja) 1994-02-01
NO931302L (no) 1993-10-07
CN1082045A (zh) 1994-02-16
KR930021638A (ko) 1993-11-22
NO931302D0 (no) 1993-04-05
CZ58193A3 (en) 1994-01-19
HUT64342A (en) 1993-12-28
DE4211474A1 (de) 1993-10-07
EP0564960A1 (de) 1993-10-13
CA2093290A1 (en) 1993-10-07

Similar Documents

Publication Publication Date Title
JP5791110B2 (ja) 新規な脂肪族置換されているピラゾロピリジンおよびその使用
HUT53879A (en) Improved process for producing decahydro-isoquinoline derivatives
EP1236726B1 (de) Triazaspiro[5.5]undecan-derivate und drogen, die dasselbe als aktiven inhaltsstoff enthalten
SK27193A3 (en) Imidazopyridine derivatives, process for their preparation and their pharmaceutical compositions
EP3137074B1 (de) Prostaglandinrezeptor-ep2-antagonisten, derivate davon, zusammensetzungen damit und verwendungen davon
UA43821C2 (uk) Піразолопіридинова сполука або її фармацевтично прийнятна сіль, фармацевтична композиція та спосіб лікування
WO2022256459A1 (en) Kras modulators and uses thereof
PT1373224E (pt) Novos derivados espirotricíclicos e seu uso como inibidores da fosfodiesterase-7
UA75054C2 (uk) Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
HU211992A9 (en) Excitatory aminoacid receptor antagonists
EP3402784B1 (de) 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivate
TW201040149A (en) Inhibitors of glucosylceramide synthase
TWI826492B (zh) 經取代四氫環戊[c]吡咯、經取代二氫吡咯，其類似物及使用其之方法
CA2756250A1 (en) 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
ES2303776A1 (es) Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b.
CA3104955A1 (en) Tyrosine amide derivatives as rho- kinase inhibitors
DE68919252T2 (de) Tetrahydroisochinoline und Tetrahydrobenzazepine und Verfahren zur Herstellung.
TW201533037A (zh) 新穎３，４－二氫－２ｈ－異喹啉－１－酮及２，３－二氫異吲哚－１－酮化合物
CA2891208C (en) Salt and polymorphic forms of (3r,4s)-l-((4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(mtdia)
HU209591B (en) Process for preparing purine derivatives and pharmaceutical preparations containing them
JP7249428B2 (ja) 疼痛に対して活性があるピペラジニル及びピペリジニルキナゾリン－４（３ｈ）－オン誘導体
HU180873B (en) Process for preparing indolyl-alkyl-amine derivatives and pharmaceutical preparations containing such compounds as active substances
JP2021500416A (ja) 疼痛及び疼痛関連状態を治療するための新規アルコキシアミノ誘導体
CA3202957A1 (en) Substituted pyridotriazine compounds and uses thereof
HU206502B (en) Process for producing new pyridobenzoindol derivatives and pharmaceutical compositions containing them